|
|
|||
| |||||||||||||||||||||||||||||||||||||||
Patient 1 was a 59-year-old-woman with recurrent diffuse large-cell lymphoma who received a second course of therapy consisting of 60 mg of etoposide per kilogram of body weight intravenously on day 1, 3 g of cyclophosphamide per square meter of body-surface area intravenously on day 2, 200 mg of paclitaxel per square meter
References
HOME | SUBSCRIBE | SEARCH | CURRENT ISSUE | PAST ISSUES | COLLECTIONS | PRIVACY | HELP | beta.nejm.org Comments and questions? Please contact us. The New England Journal of Medicine is owned, published, and copyrighted © 2008 Massachusetts Medical Society. All rights reserved. |